Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1
Clinical trial NCT04201431 · COMPLETED
Trial details
- NCT number
- NCT04201431
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-24
- Primary completion
- 2022-07-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.